Skip to content

Clinical trials

Completed Phase 4 Hyperparathyroidism, Secondary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperparathyroidism, Secondary Phase: Phase 4 Status: Completed Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20043
20054
20065
20074
20081
20095
20106
20121
20131
20141
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen7
Abbott6
Genzyme, a Sanofi Company4
AbbVie (prior sponsor, Abbott)1
Chulalongkorn University1
Clalit Health Services1
Duke University1
Fundación Senefro1
Josep M Cruzado1
Kyowa Kirin China Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperparathyroidism, Secondary34
Renal Insufficiency, Chronic14
Kidney Failure, Chronic6
Hyperparathyroidism5
Hypercalcemia4
Renal Insufficiency3
Vitamin D Deficiency3
Calcinosis2
Hyperphosphatemia2
Kidney Diseases2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.